美股市場個股詳情
NVRO Nevro
- 3.720
- -0.330-8.15%
收盤價 12/27 16:00 (美東)
- 3.720
- 0.0000.00%
盤後 16:01 (美東)
1.39億總市值-1.99市盈率TTM
4.130最高價3.690最低價36.74萬股成交量4.020今開4.050昨收139.38萬成交額1.01%換手率虧損市盈率(靜)3747.16萬總股本21.73552周最高0.51市淨率1.35億流通值3.52052周最低--股息TTM3638.90萬流通股188.140歷史最高--股息率TTM10.86%振幅3.520歷史最低3.793平均價1股每手
關於Nevro公司
Nevro Corp 是一家醫療設備公司。 其主要產品是 HFX 脊髓刺激 (SCS) 平臺，其中包括 Senza SCS 系統，這是一種用於治療慢性疼痛的循證神經調節系統。 Senza 產生電脈衝來緩解疼痛。 該系統由醫生植入，由患者控制。 它由導線、試驗刺激器、植入式脈衝發生器、手術工具、臨牀醫生筆記本電腦編程器、患者遙控器和移動充電器組成。 該公司的大部分收入來自美國。
公司介紹
公司代碼NVRO
公司名稱Nevro
上市日期2014/11/06
發行價格18.00
成立日期2006
CEOMr. Kevin R. Thornal
所屬市場紐交所
員工數量1215
年結日12-31
公司地址1800 Bridge Parkway
城市Redwood City
省份加利福尼亞州
國家美國
郵編94065
電話1-650-251-0005
董事高管
- 姓名
- 職務
- 年薪
- Kevin R. Thornal
- Director, Chief Executive Officer and President
- 1145.35萬
- Roderick H. MacLeod
- Senior Vice President and Chief Financial Officer
- 257.72萬
- Kashif Rashid
- Senior Vice President, Corporate Development and Chief Legal Officer
- 255.37萬
- Christopher Christoforou
- Chief Operating Officer
- --
- Greg Siller
- Senior Vice President and Chief Commercial Officer
- 355.81萬
- Shana Ross
- Senior Vice President and Chief Human Resources Officer
- --
- Dr. David Caraway, PhD
- Senior Vice President and Chief Medical Officer
- --
- Donald A. Middlebrook
- Senior Vice President, Clinical, Regulatory and Quality
- --
- Peter A. Socarras
- Vice President, General Counsel and Corporate Secretary
- --
- D. Keith Grossman
- Non-Executive Chairman of the Board
- 136.44萬
- Elizabeth H. Weatherman
- Independent Director
- 25.92萬
- Shawn T. McCormick
- Independent Director
- 24.70萬
- Susan E. Siegel
- Independent Director
- 24.30萬
- Kirt P. Karros
- Independent Director
- --
- Sri Kosaraju
- Independent Director
- 24.30萬
- Michael F. DeMane
- Lead Independent Director
- 28.50萬
- Karen N. Prange
- Independent Director
- 25.30萬
- Kevin O’Boyle
- Independent Director
- 26.00萬
熱議
美股
綜合熱度
股票代碼
最新價
升跌幅
暫無數據